Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Array BioPharma claims novel Pim kinase inhibitors

March 16, 2010

Novel MIF inhibitors identified by Yale University scientists for cancer therapy

March 16, 2010

Pfizer reports on phase III Sutent trials in advanced breast cancer

March 15, 2010

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer

March 15, 2010

FDA accepts for review Abbott's Lupron sNDA for prostate cancer

March 15, 2010

Pfizer discontinues phase III trial of figitumumab in NSCLC

March 15, 2010

French scientists claim epipodophyllotoxin derivatives with antitumor activity

March 15, 2010

Astex and Novartis claim the discovery of novel CDK4 inhibitors

March 12, 2010

Hedgehog pathway antagonist GDC-0449 shows clinical promise in metastatic basal cell carcinoma

March 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...